Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Añadir filtros








Intervalo de año
2.
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons ; : 270-275, 2011.
Artículo en Coreano | WPRIM | ID: wpr-785067
3.
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons ; : 178-182, 2010.
Artículo en Coreano | WPRIM | ID: wpr-784959
4.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 291-302, 2010.
Artículo en Inglés | WPRIM | ID: wpr-191903

RESUMEN

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a side effect of Bisphosphonates (BPs) use. These days, oral bisphosphonates are normally prescribed to treat osteoporosis. Intravenous BPs are used extensively to treat osteolytic bone lesions related to multiplemyeloma and bone metastasis of solid cancers, breast cancer or prostate cancer. As the prescription of BPs is universalized and the number of people treated with BPs is increasing, an accurate understanding and proper management of BRONJ are required. The aim of this study was to improve the clinicians'understanding of BRONJ by reviewing the literature. To achieve this, this paper introduces case reports as well as the current concept of BRONJ based on the 2009 updates by American Association of Oral and Maxillofacial (AAOMS) including the definition, epidemiology, etiology, diagnosis, treatment and prevention of BRONJ.


Asunto(s)
Osteonecrosis de los Maxilares Asociada a Difosfonatos , Neoplasias de la Mama , Difosfonatos , Enfermedades Maxilomandibulares , Metástasis de la Neoplasia , Osteonecrosis , Osteoporosis , Prescripciones , Neoplasias de la Próstata
5.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 128-133, 2010.
Artículo en Coreano | WPRIM | ID: wpr-186965

RESUMEN

Mesenchymal chondrosarcoma is very aggressive and represents approximately 1% of all chondrosarcomas. While it affects a very wide age range, the peak frequency is in the second decade of life. It may occur in the head and rib region with a predilection for the maxillofacial skeleton. The small cell undifferentiated component may assume a hemangiopericytoma-like vascular pattern and should be distinguished from hemangiopericytoma. Treatment is en bloc resection, the intended tissue margins of excision should be designed to extend well beyond the actual tumor margin, as mesenchymal chondrosarcomas. Aggressive behavior of mesenchymal chondrosarcoma of the jaw, with a tendency for delayed recurrence and metastasis even many years after treatment. The most frequent site of metastasis was the lung. Here we present 52 years old , female case of mesenchymal chondrosarcoma occurs on Rt. mandible.


Asunto(s)
Femenino , Humanos , Condrosarcoma , Condrosarcoma Mesenquimal , Cabeza , Hemangiopericitoma , Maxilares , Pulmón , Mandíbula , Metástasis de la Neoplasia , Recurrencia , Costillas , Esqueleto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA